What is Triomphe?
Considered "the elixir of
youth and well-being" by women who have taken Triomphe, this product is a
natural hormone designed for people in perimenopause, menopause and
post-menopause. Phytohormones (phytoestrogen) are naturally active compounds
that come from plants. Phytoestrogen is not a nutrient but a micro plant
constituent. Once ingested, they act in the body similarly to the natural hormones
estrogen. For this reason, they are called phytoestrogens. Although their
effect is slower than synthetic estrogens, it remains as effective.
Before using naturist therapy, i.e.,
standardized plant extracts, we conducted several studies. For years we have
studied in a bibliographical and practical way several factors influencing the
hormonal level, both in terms of the eating habits of various ethnic groups and
the way of life in said groups.
Due to their similar chemical
structure, isoflavones can mimic or modulate the action of estrogen naturally
produced by the body.
Triomphe is widely used by people who need relief from menopausal symptoms and disorders, such as:
- hot flashes
- night sweats
- nervousness
- excessive irritability
- depression
- osteoporosis
- atrophy of organs and tissues
- vaginal dryness
- mammary gland atrophy
- recurrent cystitis
- incontinence
- improvement of cognitive functions
- memory improvement
- improvement of hydration, elasticity and tone of the dermis
What is the advantage of Triomphe?
Numerous clinical and experimental data have demonstrated
the favourable influence of estrogen on body composition, specifically on
the distribution of fat mass as well as on various pathways regulating
carbohydrate metabolism.
Estrogens directly affect the central nervous
system by modulating the balance between food intake and energy expenditure.
Their actions on peripheral targets enhance insulin sensitivity in the liver,
adipose tissue and skeletal muscle.
Recently, the influence on intestinal microbiota has
been identified. Estrogen deficiency impairs body composition and metabolic
flexibility, increasing the risk for metabolic and vascular
disease.
After menopause, the ovaries stop producing estrogen. The
tissues sensitive to estrogens (skin, mucous membranes and skeletons)
undergo modifications, in particular, they atrophy.
This stop leads to the reduction of collagen synthesis
resulting in a loss of tone and thickness of the skin and causing dryness and itching, wrinkles and skin fragility.
After years of research and trying several compositions, we
have developed the ideal formula to counter the undesirable effects of
menopause and offer a completely safe product with no side effects.
We have chosen to combine the effect of soy and lupulus isoflavones.
Soy isoflavone acts predominantly on hot flashes, night sweats, osteoporosis
and reduction of blood lipids. Lupus acts on sleep disorders, anxiety and
agitation. For the past 25 years we have observed how the synergy of these
components manages to control the unpleasant symptoms of menopause.
How to maximize the therapeutic effect of Triomphe?
Studies indicate that up to 30% of the collagen in the skin
is lost in the first 5 years after menopause. After that, it decreases at a
rate of 2% per year.
Polito et al. suggested that isoflavones may be comparable
in efficacy to estrogen hormone therapy in reversing skin changes associated
with menopause.
For overall health for menopausal people, the Triomphe -
Prometheus complex stands out for its rich content of anti-aging active
ingredients such as anti-inflammatory, antioxidant and regenerative at all
levels.
What are the main effects of taking the Triomphe product?
The product's primary purpose is to normalize the
lifestyle and create a general state of well-being. It reduces the unpleasant
symptoms of menopause, such as palpitations, vasomotor disorders, migraines,
dizziness, excessive fatigue, etc.
Why and when to take Triomphe?
Menopause is not a pathological condition. On the contrary,
it is a normal physiological stage in a woman's life. This new stage is
characterized by creating and establishing a new balance involving most physiological and metabolic functions. In many cases, the
constraints of the active life of contemporary women, whether in the workplace,
family or both combined, do not leave the body the possibility of achieving
balance on its own.
The normal estrogen secretion of a premenopausal woman is 50
to 350ug/24 h. For a postmenopausal woman to have balanced work, family, and
social life, the minimum estrogen concentration should be 30-50 ug/24 hours.
Research from 35 studies proves that soy isoflavone supplements increase 14%
estradiol (estrogen) levels in postmenopausal women.
The ability of intestinal metabolism to transform
isoflavones into their active form, called equol, depends on the composition of
the intestinal flora. We have noticed that by taking Triomphe with yogurt, the
results (reduction of unpleasant symptoms of menopause) are increased.
For how long should I take Triomphe?
Administration of the product is recommended for a minimum
of six months. More specifically, the administration can be stopped when the
symptoms of menopause are reduced and can be bearable. Triomphe has been
designed to be administered over a very long period without suffering the side
effects induced by synthetic products.
The administration of the product can be done for an
indefinite period, and the product can continue to be taken even after having
exceeded the period of menopausal crisis to ensure the physical and
psychological well-being of the postmenopausal person.
Who should take Triomphe?
People in premenopause, menopause and postmenopause for whom this new
stage of life creates unpleasant symptoms.
Recommended dosage of Triomphe product
Premenopausal period: 2 capsules per day
Menopause period: take between 1 and 2 capsules, 3 times a day. The dose
can be adjusted according to the symptomatology. In the most common cases, in
the period of onset of menopause (after a year without menstruation) it is
recommended to increase the dose to 2 capsules, 3 times a day until the
disappearance of symptoms, following which, a dose maintenance is suggested,
i.e. 2 capsules per day.
Postmenopausal period: 2 capsules per day
Please note that the information published on this page is general and is intended for additional information purposes only.
Note: hypertext links leading to other sites need to be continuously updated. It's possible a link become not found. You can use the search tools to find the information you'd like.
The Active Components of Triomphe
Triomphe is composed of Soy Isoflavones Extract and Humulus Lupulus. Both components work together to offer pre-menopausal, menopausal and post-menopausal women as much comfort as is needed during this time in their lives. The mix of soy isoflavones extract, and Humulus lupulus is beneficial due to their complementary effects on alleviating menopausal symptoms. Several studies have investigated the effects of combining soy isoflavones and Humulus lupulus for menopausal symptom relief. For example, a 2015 randomized controlled trial published in the journal Phytomedicine found that a supplement containing both soy isoflavones and hop extract significantly reduced the frequency and severity of hot flashes and improved sleep and general well-being in menopausal women.
Soy Isoflavones Extract
Soy isoflavones are a group of phytoestrogens compounds found in soybeans that have estrogen-like effects on the human body. Menopause is a time in a woman's life when estrogen levels decline, which can cause various symptoms such as hot flashes, night sweats, and mood swings.
Research has shown that soy isoflavones can help alleviate menopausal symptoms, and there is also some evidence that they may benefit menopausal women's bone health. Research suggests that soy isoflavones bind to estrogen receptors in the body, thus mimicking the effects of estrogen and helping to alleviate symptoms associated with menopause.
A meta-analysis of 17 randomized controlled trials found that soy isoflavone supplements significantly reduced the frequency and severity of hot flashes. Another study showed that soy isoflavone supplements improve bone mineral density during postmenopause, which can help reduce the risk of osteoporosis.
A 2006 randomized, double-blind, placebo-controlled study published in Obstetrics and Gynecology found that women taking soy isoflavone supplements experienced a significant reduction in hot flashes and other menopausal symptoms compared to those taking a placebo.
A 2012 meta-analysis published in the journal Maturitas reviewed 17 randomized controlled trials and found that soy isoflavone consumption was associated with a significant reduction in the frequency and severity of hot flashes among menopausal women.
A 2019 systematic review published in Nutrients found that soy isoflavones had a positive effect on menopausal symptoms such as hot flashes, vaginal dryness, and sleep disturbances. The authors noted that the evidence supports the use of soy isoflavones as an alternative or complementary therapy to hormone replacement therapy.
Given their estrogenic, antioxidant and anti-inflammatory effects, soy isoflavones have also proven efficient for premenopausal women.
- Estrogenic effects - Soy isoflavones can bind to estrogen receptors and exert estrogen-like effects on the body.
- Antioxidant effects - Soy isoflavones also have antioxidant properties, which may help protect against cellular damage.
- Anti-inflammatory effects - Some studies have suggested that soy isoflavones may have anti-inflammatory effects, which could be beneficial for preventing chronic diseases.
A randomized, double-blind, placebo-controlled trial published in the Journal of Women's Health found that soy isoflavone supplements reduced menstrual pain and improved quality of life in menstruating women.
A pilot study published in the Journal of Human Nutrition and Dietetics found that soy isoflavones improved insulin resistance and reduced inflammation in premenopausal women with metabolic syndrome.
A systematic review published in Obstetrics & Gynecology Science concluded that soy isoflavones may help improve bone health and reduce the risk of osteoporosis in premenopausal women.
Humulus Lupulus
Soy Humulus Lupulus, also known as hops, is commonly used in beer brewing but has also been used for centuries as a natural remedy for menopausal symptoms such as hot flashes and sleep disturbances. Recent medical research suggests that hops may indeed have benefits for menopausal women.
One of the primary active components in hops is 8-prenylnaringenin (8-PN), which has been shown to have estrogenic activity. This means that it can mimic the effects of estrogen in the body, which can help alleviate menopausal symptoms.
A 2016 randomized, double-blind, placebo-controlled trial published in the Journal of Women's Health found that a supplement containing hops extract reduced the frequency and severity of hot flashes in menopausal women compared to a placebo. The study also found that the hops supplement improved sleep quality and reduced anxiety and depression.
Another study published in the Journal of Alternative and Complementary Medicine found that hops extract reduced the number and intensity of hot flashes in women with a history of breast cancer. The authors concluded that hops extract could be a safe and effective alternative to hormone replacement therapy for women with breast cancer.
Current studies suggest that Humulus Lupulus is a promising natural alternative to traditional hormone replacement therapy.
References
Hwang CS, Kwak HS, et al. Isoflavone metabolites and their in vitro dual functions: They can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol. 2006 Nov;101(4-5):246-253.
Agence française de sécurité sanitaire des aliments (AFSSA). Sécurité et bénéfices des phyto-estrogènes apportés par l’alimentation — Recommandations (rapport complet de 370 pages), mars 2005. [Consulté le 20 avril 2010] www.academie-medecine.fr
Song KB, Atkinson C, et al. Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr. 2006 May;136 (5) : 1347-51.
Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr. 2002;132(12):3577-3584. Texte intégral : http://jn.nutrition.org
Setchell KD, Cole SJ. Method of defining equol-producer status and its frequency among vegetarians. J Nutr. 2006 Aug;136(8):2188-93.
Niculescu MD, Pop EA, et al. Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not. J Nutr Biochem. 2006 Sep 7
Meyer BJ, Larkin TA, et al.Limited lipid-lowering effects of regular consumption of whole soybean foods. Ann Nutr Metab. 2004;48(2):67-78.
Yuan JP, Wang JH, Liu X. Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health. Mol Nutr Food Res. 2007 Jul;51(7):765-81. Review.
Messina M, Nagata C, Wu AH. Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer. 2006;55(1):1-12
de Kleijn MJ, van der Schouw YT, et al. Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study(1-4). J Nutr. 2001;131(6):1826-1832. Texte intégral : jn.nutrition.org
USDA-Iowa State University Database on the Isoflavone Content of Foods, Release 1.3 – 1999. [Consulté le 20 avril 2010] www.nal.usda.gov
The Linus Pauling Institute. Micronutrient Information Center, Soy isoflavones. [Consulté le 16 mai 2008] lpi.oregonstate.edu
Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995;333(5):276-282. Texte intégral : content.nejm.org
Reynolds K, Chin A, et al. A meta-analysis of the effect of soy protein supplementation on serum lipids. Am J Cardiol. 2006 Sep 1 ; 98 (5) : 633-40.
Balk E, Chung M, et al. Effects of soy on health outcomes. Evid Rep Technol Assess (Summ). 2005 Aug;(126):1-8. Review. Texte intégral : www.ahrq.gov
Sacks FM, Lichtenstein A, et al. Soy protein, isoflavones, and cardiovascular health: a summary of a statement for professionals from the american heart association nutrition committee. Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1689-92. Review. Texte integral : http://atvb.ahajournals.org
Dewell A, Hollenbeck PL, Hollenbeck CB. Clinical review: a critical evaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations. J Clin Endocrinol Metab. 2006 Mar;91(3):772-80. Review.
Weggemans RM, Trautwein EA. Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur J Clin Nutr. 2003 Aug;57(8):940-6.
Geller SE, Studee L. Soy and red clover for mid-life and aging. Climacteric. 2006 Aug;9(4):245-63. Review. Texte intégral : www.pubmedcentral.nih.gov
Zhan S, Ho SC. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr. 2005 Feb;81(2):397-408. Texte intégral : www.ajcn.org
Taku K, Umegaki K, et al. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr. 2007 Apr;85(4):1148-56. Erratum in: Am J Clin Nutr. 2007 Sep ; 86 (3) : 809. Texte integral : www.ajcn.org
Fuchs D, Vafeiadou K, et al. Proteomic biomarkers of peripheral blood mononuclear cells obtained from postmenopausal women undergoing an intervention with soy isoflavones. Am J Clin Nutr. 2007 Nov;86(5):1369-75.
Clerici C, Setchell KD, et al. . Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. J Nutr. 2007 Oct ; 137 (10) : 2270-8
Atteritano M, Marini H, et al. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2007 Aug;92(8):3068-75.
Setchell KD, Lydeking-Olsen E. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies.Am J Clin Nutr. 2003 Sep ; 78 (3 Suppl) : 593S-609S. Review. Texte intégral : http://www.ajcn.org
Reinwald S, Weaver CM. Soy isoflavones and bone health: a double-edged sword?J Nat Prod. 2006 Mar;69(3):450-9. Review.
Messina M, Ho S, Alekel DL. Skeletal benefits of soy isoflavones: a review of the clinical trial and epidemiologic data. Curr Opin Clin Nutr Metab Care. 2004 Nov;7(6):649-58. Review.
Whelan AM, Jurgens TM, Bowles SK. Natural health products in the prevention and treatment of osteoporosis: systematic review of randomized controlled trials. Ann Pharmacother. 2006 May;40 (5) : 836-49. Review
Ma DF, Qin LQ, et al. Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials. Clin Nutr. 2008 Feb;27(1):57-64
Ma DF, Qin LQ, et al. Soy isoflavone intake inhibits bone resorption and stimulates bone formation in menopausal women: meta-analysis of randomized controlled trials.Eur J Clin Nutr 2008 Feb;62(2):155-61
Vatanparast H, Chilibeck PD. Does the effect of soy phytoestrogens on bone in postmenopausal women depend on the equol-producing phenotype?Nutr Rev. 2007 Jun;65(6 Pt 1):294-9. Review.
Wu J, Oka J, et al. Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial. Menopause. 2007 Sep-Oct ; 14 (5) : 866-74.
Brink E, Coxam V, et al; PHYTOS Investigators. Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study. Am J Clin Nutr. 2008 Mar;87(3):761-70.
Tempfer CB, Bentz EK, et al. Phytoestrogens in clinical practice: a review of the literature. Fertil Steril. 2007 Jun;87(6):1243-9. Treatment of menopause-associated vasomotor symptoms: position statement of 37
The North American Menopause Society (2004). www.menopause.org.
Lethaby AE, Brown J, et al. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst Rev. 2007 Oct 17;(4) : CD001395. Review.
Jou HJ, Wu SC, et al. Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones. Int J Gynaecol Obstet. 2008 Apr 8.
D’Anna R, Cannata ML, et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study. Menopause. 2007 Jul-Aug;14(4):648-55.
Williamson-Hughes PS, Flickinger BD, et al. Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies. Menopause. 2006 Sep-Oct ; 13 (5) : 831-9. Review.
Perabo FG, Von Löw EC, et al. Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Prostatic Dis. 2008;11(1):6-12. Review.
Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst. 2006 Apr 5;98(7):459-71. Texte intégral : jnci.oxfordjournals.org
Qin LQ, Xu JY, et al. Soyfood intake in the prevention of breast cancer risk in women: a meta-analysis of observational epidemiological studies. J Nutr Sci Vitaminol (Tokyo). 2006 Dec;52(6):428-36. Texte intégral : www.jstage.jst.go.jp
Vaishampayan U, Hussain M, et al. Lycopene and soy isoflavones in the treatment of prostate cancer. Nutr Cancer. 2007;59(1):1-7.
Hamilton-Reeves JM, Rebello SA, et al. Soy protein isolate increases urinary estrogens and the ratio of 2:16alpha-hydroxyestrone in men at high risk of prostate cancer. J Nutr. 2007 Oct ; 137 (10) : 2258-63.
Duffy R, Wiseman H, File SE. Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacol Biochem Behav. 2003;75:721–729.
Kritz-Silverstein D, Von Muhlen D, et al. Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause. 2003;10:196–202.
File SE, Hartley DE, et al. Cognitive improvement after 6 weeks of soy supplements in postmenopausal women is limited to frontal lobe function. Menopause. 2005;12:193–201.
Casini ML, Marelli G, et al. Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized, double-blind, crossover, placebo-controlled study. Fertil Steril. 2006 Apr;85(4):972-8.
Kreijkamp-Kaspers S, Kok L, et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA. 2004 Jul 7;292(1):65-74. Texte intégral : http://jama.ama-assn.org
Fournier LR, Ryan Borchers TA, et al. The effects of soy milk and isoflavone supplements on cognitive performance in healthy, postmenopausal women. J Nutr Health Aging. 2007 Mar-Apr;11(2):155-64.
Ho SC, Chan AS, et al. Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: a double-blind, randomized, controlled trial. Menopause. 2007 May-Jun ; 14 (3 Pt 1) : 489-99.
Zhao L, Brinton RD. WHI and WHIMS follow-up and human studies of soy isoflavones on cognition. Expert Rev Neurother. 2007 Nov;7(11):1549-64. Review.
Velasquez MT, Bhathena SJ. Role of dietary soy protein in obesity. Int J Med Sci. 2007 Feb 26;4(2):72-82. Review.Texte intégral : www.medsci.org
Quella SK, Loprinzi CL, et al. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol. 2000 Mar;18(5):1068-74
Van Patten CL, Olivotto IA, et al. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. J Clin Oncol. 2002 Mar 15;20(6):1449-55
Nikander E, Kilkkinen A, et al. A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet Gynecol. 2003 Jun;101(6):1213-20
MacGregor CA, Canney PA, et al. A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer. Eur J Cancer. 2005 Mar;41(5):708-14
Messina M, McCaskill-Stevens W, Lampe JW. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst. 2006 Sep 20 ; 98 (18) : 1275-84. Review
Martinez ME, Thomson CA, Smith-Warner SA. Soy and breast cancer: the controversy continues. J Natl Cancer Inst. 2006 Apr 5;98(7):430-1. Texte intégral : http://jncicancerspectrum.oxfordjournals.org